Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase.
It would need to be repurchased by the trainee if not completed in the allotted time period.
This course is no longer available.
You will need to repurchase if you wish to take the course again.

Description

TCC from A to Z with Tavocept Transitional cell carcinoma (TCC) is the most common bladder cancer diagnosed in dogs. Unfortunately, canine TCC is generally not diagnosed until it has invaded nto the bladder wall, at which point available treatment options are largely unsuccessful. Thus, canine urinary bladder TCC is virtually incurable at this time. The necessary elements to move us closer to a cure include earlier detection and more effective prevention of metastatic disease. A summary of current diagnostic methods and treatment options will be provided and ongoing research will be discussed. Considerably less information is available with regard to feline bladder cancer. A summary of clinical features, biological behavior, and treatment outcome reported for cats with TCC will be provided and discussed, time permitting.

Objectives

Objectives

A summary of current diagnostic methods and treatment options will be provided and ongoing research will be discussed. Considerably less information is available with regard to feline bladder cancer. A summary of clinical features, biological behavior, and treatment outcome reported for cats with TCC is provided here.

Dr. Carolyn J Henry is a Full Professor of Oncology at the University of Missouri, with dual appointments in the College of Veterinary Medicine and the School of Medicine, USA. A graduate of Auburn University College of Veterinary Medicine, Dr. Henry practiced small animal and emergency medicine in Georgia and Alabama before returning to Auburn to complete an MS degree program and an Oncology Residency. Dr. Henry became board certified in Oncology in 1994 and served on the faculty at Washington State University for three years before accepting a faculty position at the University of Missouri’s College of Veterinary Medicine in 1997. She also serves as the Associate Director of Research at the Ellis Fischel [human] Cancer Center at the University of Missouri, Faculty Facilitator for the One Health/One Medicine Initiative of the Mizzou Advantage Program within the Provost’s Office and Associate Dean for Research and Graduate Studies at the College of Veterinary Medicine. She is past president of both the Veterinary Cancer Society and the American College of Veterinary Internal Medicine Specialty of Oncology and is a member of the European Society of Veterinary Oncology and Fellow in the National Academies of Practice. Dr. Henry’s textbook, Cancer Management in Small Animal Practice, was published in 2010 and she has authored or coauthored over 80 peer-reviewed manuscripts. Dr. Henry’s research interests center on translational models of human disease, with bladder cancer and novel drug therapies being areas of emphasis.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s: